Education
About Us
Working with TipRanks
Follow Us
3D Medicines, Inc. (HK:1244)
:1244
3D189
Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Leukemia, Higher-Risk Myelodysplastic Syndrome
Phase I
Active Not Recruiting
Study of 3D189 in Patients With Hematologic Malignancies
Mar 19, 2022
―
3D1002 (50 Mg)(Phase Iia), 3D1002 (100 Mg)(Phase Iia), 3D1002 (150 Mg)(Phase Iia), 3D1002 Monotherapy (Phase Iib), Oxycontin Monotherapy (Phase Iib), 3D1002 + Oxycontin (Phase Iib)
Cancer Pain
Phase II
Not Yet Recruiting
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
Jan 24, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does 3D Medicines, Inc. (1244) have in its pipeline
1244 is currently developing the following drugs: 3D189, 3D1002 (50 Mg)(Phase Iia), 3D1002 (100 Mg)(Phase Iia), 3D1002 (150 Mg)(Phase Iia), 3D1002 Monotherapy (Phase Iib), Oxycontin Monotherapy (Phase Iib), 3D1002 + Oxycontin (Phase Iib). These drug candidates are in various stages of clinical development as the company works toward FDA approval.